MoonLake Immunotherapeutics (MLTX) Financials
MLTX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 573.9 million | 145.8 million |
| March 31, 2026 | 400.4 million | 146.4 million |
| Dec. 31, 2025 | 424.4 million | 120.0 million |
| Sept. 30, 2025 | 414.3 million | 123.1 million |
MLTX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -55.6 million | 2.5 million |
| March 31, 2026 | -66.3 million | 13.4 million |
| Dec. 31, 2025 | -58.8 million | 3.6 million |
| Sept. 30, 2025 | -44.5 million | 3.7 million |
MLTX Net Income
No data available :(
MLTX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 537.0 million | 99.5 million | 2.0 million |
| March 31, 2026 | 357.9 million | 99.9 million | 920000 |
| Dec. 31, 2025 | 394.0 million | 74.5 million | 374000 |
| Sept. 30, 2025 | 380.5 million | 73.7 million | 2.0 million |
MLTX Shares Outstanding
MLTX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 50.2 million | 11.4 million | - |
| March 31, 2026 | - | 53.7 million | 15.5 million | - |
| Dec. 31, 2025 | - | 57.5 million | 9.2 million | - |
| Sept. 30, 2025 | - | 60.6 million | 10.8 million | - |
MLTX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 845000 |
| Dec. 31, 2025 | - | 751000 |
| Sept. 30, 2025 | - | 745000 |
MLTX Revenue by Segment
Graph available only for paid members. Upgrade to see it.
MLTX
Price: $15.87
52 week price:
Earnings Per Share: -3.84 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.4 billion